| Page 70 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.
  1. Home

Using Integrative Medicine to help patients through Treatment- a recent conversation with Dr. M. Kogan

Dr. Mikhail Kogan, Medical Director of the GW Center for Integrative Medicine, discusses incorporating Integrative Medicine into a patient's treatment plan. He describes using yoga, meditation, and other techniques to help patients while they are in treatment for bone marrow failure conditions.

Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria

Author(s): 
Stern RM, Connell NT
Primary Author: 
Stern RM
Journal Title: 
Therapeutic Advances in Hematology
Original Publication Date: 
Sep 2019

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare stem cell disorder characterized by

Bone Marrow Disease(s): 

Germline DDX41 mutations define a significant entity within adult MDS/AML patients

Author(s): 
Sébert M, Passet M, Raimbault A, Rahmé R, Raffoux E, Sicre de Fontbrune F, Cerrano M, Quentin S, Vasquez N, Da Costa M, Boissel N, Dombret H, Peffault de Latour R, Socié G, Itzykson R, Fenaux P, Soulier J, Adès L, Clappier E
Primary Author: 
Sebert M
Journal Title: 
Blood
Original Publication Date: 
Sep 2019

Germline DDX41 mutations are involved in familial

Bone Marrow Disease(s): 

Phase 2 Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes

Author(s): 
Santini V, Valcárcel D, Platzbecker U, Komrokji RS, Cleverly A, Lahn MM, Janssen J, Zhao Y, Chiang A, Giagounidis A, Guba SC, Sridharan A, Gueorguieva I, Girvan A, da Silva Ferreira M, Bhagat TD, Pradhan K, Steidl U, Will B, Verm A
Primary Author: 
Santini V
Journal Title: 
Clinical Cancer Research: an official Journal of the American Association of Cancer Research
Original Publication Date: 
Sep 2019

PURPOSE:

Bone Marrow Disease(s): 

Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms

Author(s): 
Loghavi S, Wang SA
Primary Author: 
Loghavi S
Journal Title: 
Surgical Pathology Clinic
Original Publication Date: 
Jul 2019

In this article we provide a practical and comprehensive review of myeloid neoplasms with overlapping myelodysplastic (MDS) and myeloproliferative (MPN) features, with emphasis on recent updates in classification, particularly the utility of morphologic, cytogenetic, and molecular findings in better defining and classifying these disease entities.

Bone Marrow Disease(s): 

RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis

Author(s): 
Zeidan AM, Zhu W, Stahl M, Wang R, Huntington SF, Giri S, Podoltsev NA, Gore SD, Ma X, Davidoff AJ
Primary Author: 
Zeidan AM
Journal Title: 
Leukemia & Lymphoma
Original Publication Date: 
Jun 2019

Most patients with lower risk

Bone Marrow Disease(s):